44，Wanless IR，Lentz JS.Fatty liver hepatitis(steatohepatitis) and obesity:an autopsy study with analysis of risk factors.Hepatology，1990；12(5):110
55，Cotrim HP，Parana R，Portugal M，et al.Nonalcoholic steatohepatitis(NASH) and industrial toxins:follow up of patients removed from one industrial area(abstract).Hepatology，1997；26(suppl):149A
66，Geroge DK，Goldwrum S，Macdonald GA，et al.Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increases of fibrosis.Gastroenterology，1998；114(2):311
77，James LFW，Day CP.Nonalcoholic steatohepatitis(NASH):a disease of merging identity and importance.J Hepatol，1998；29(3):495
88，Sorbi D，Boynton J，Linder KD.The ratio of aspartate aminotransferase to alanine aminotransferase:potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.Am J Gastroenterol，1999；94(4):1018
99，Matteoni CA，Younossi ZM，Gramlich T，et al.Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severtiy.Gastroenterology，1999；116(6):1413
1010，Caldwell SH，Oelsner DH，Iezzoni JC，et al.Cryptogenic cirrhosis:clinical characterization and risk factors for underlying disease.Hepatology，1999；29(3):664
